Overview

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
Albumin in the urine is usually a signal that you might be at risk of cardiovascular complications. The purpose of this study is to determine if the albumin in your urine can be decreased by the treatment regimen that consists of irbesartan taken at the same time with ramipril.
Phase:
Phase 4
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborator:
Sanofi
Treatments:
Irbesartan
Ramipril